TY - JOUR
T1 - What's New in Sexually Transmitted Infection Management
T2 - Changes in the 2010 Guidelines from the Centers for Disease Control and Prevention
AU - Mark, Hayley
AU - Jordan, Elizabeth T.
AU - Cruz, Jomarie
AU - Warren, Nicole
N1 - Funding Information:
This work was supported by USPHS grant NS-07606 from the National Institute of Neurological and Communicative Disorders and Stroke.
PY - 2012/5
Y1 - 2012/5
N2 - Screening, treatment, and follow-up of sexually transmitted infections (STIs) are an important part of the role of women's health care providers. Keeping abreast of new and changing treatment guidelines is crucial to providing competent care. The Sexually Transmitted Diseases Treatment Guidelines, produced every 4 years by the Centers for Disease Control and Prevention, summarize current evidence on prevention, diagnosis, and treatment of STIs. The purpose of this article is to review the changes in the 2010 guidelines from the previous 2006 guidelines. These changes include new diagnostic tests for bacterial vaginosis, Neisseria gonorrhoeae, and human papillomavirus; new treatment recommendations for bacterial vaginosis, gonorrhea, and genital warts; the increasing prevalence of antimicrobial-resistant N gonorrhoeae; new criteria for spinal fluid examination to evaluate for neurosyphilis; and the emergence of azithromycin-resistant Treponema pallidum.
AB - Screening, treatment, and follow-up of sexually transmitted infections (STIs) are an important part of the role of women's health care providers. Keeping abreast of new and changing treatment guidelines is crucial to providing competent care. The Sexually Transmitted Diseases Treatment Guidelines, produced every 4 years by the Centers for Disease Control and Prevention, summarize current evidence on prevention, diagnosis, and treatment of STIs. The purpose of this article is to review the changes in the 2010 guidelines from the previous 2006 guidelines. These changes include new diagnostic tests for bacterial vaginosis, Neisseria gonorrhoeae, and human papillomavirus; new treatment recommendations for bacterial vaginosis, gonorrhea, and genital warts; the increasing prevalence of antimicrobial-resistant N gonorrhoeae; new criteria for spinal fluid examination to evaluate for neurosyphilis; and the emergence of azithromycin-resistant Treponema pallidum.
KW - Bacterial vaginosis
KW - Gonorrhea
KW - Hepatitis C
KW - Herpes
KW - Human papillomavirus
KW - Sexually transmitted infections
KW - Syphilis
KW - Trichomoniasis
UR - http://www.scopus.com/inward/record.url?scp=84862113626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862113626&partnerID=8YFLogxK
U2 - 10.1111/j.1542-2011.2012.00179.x
DO - 10.1111/j.1542-2011.2012.00179.x
M3 - Review article
C2 - 22594866
AN - SCOPUS:84862113626
VL - 57
SP - 276
EP - 284
JO - Journal of Midwifery and Women's Health
JF - Journal of Midwifery and Women's Health
SN - 1526-9523
IS - 3
ER -